Scienture Holdings, Inc. (SCNX) stock
SCNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.76−0.23 (-7.69%)
Close on Nov 17, 2026Market cap $113.34MP/E –Yield –
Scienture total assets
Total assets on the balance sheet at the end of each period.
Scienture's total assets was $87.73M at Jun 30, 2026. For fiscal 2025 it was $84.18M, down 19.7% from the year before. Over ten years it grew 45.2% a year on average. The highest annual figure on record is $104.85M in fiscal 2024.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $84.18M | -19.7% |
| FY2024 | Dec 31, 2024 | $104.85M | +736.6% |
| FY2023 | Dec 31, 2023 | $12.53M | +237.8% |
| FY2022 | Dec 31, 2022 | $3.71M | -35.7% |
| FY2021 | Dec 31, 2021 | $5.77M | -41.1% |
| FY2020 | Dec 31, 2020 | $9.79M | +75.8% |
| FY2019 | Dec 31, 2019 | $5.57M | +150.1% |
| FY2018 | Dec 31, 2018 | $2.23M | +260.8% |
| FY2017 | Dec 31, 2017 | $617.48K | +83.2% |
| FY2016 | Dec 31, 2016 | $337.12K | -83.4% |
| FY2015 | Dec 31, 2015 | $2.03M | +65.9% |
| FY2014 | Dec 31, 2014 | $1.22M | +202.6% |
| FY2013 | Dec 31, 2013 | $403.87K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $87.73M | +4.2% |
| Q1 FY2026 | Mar 31, 2026 | $80.66M | -4.2% |
| Q4 FY2025 | Dec 31, 2025 | $84.18M | -19.7% |
| Q3 FY2025 | Sep 30, 2025 | $104.83M | +11.2% |
| Q2 FY2025 | Jun 30, 2025 | $84.18M | +466.9% |
| Q1 FY2025 | Mar 31, 2025 | $84.18M | -19.7% |
| Q4 FY2024 | Dec 31, 2024 | $104.85M | +736.6% |
| Q3 FY2024 | Sep 30, 2024 | $94.26M | +335.3% |
| Q2 FY2024 | Jun 30, 2024 | $14.85M | +161.8% |
| Q1 FY2024 | Mar 31, 2024 | $104.85M | +2496.8% |
| Q4 FY2023 | Dec 31, 2023 | $12.53M | +237.8% |
| Q3 FY2023 | Sep 30, 2023 | $21.65M | +383.3% |
| Q2 FY2023 | Jun 30, 2023 | $5.67M | 0.0% |
| Q1 FY2023 | Mar 31, 2023 | $4.04M | -30.9% |
| Q4 FY2022 | Dec 31, 2022 | $3.71M | -35.7% |
| Q3 FY2022 | Sep 30, 2022 | $4.48M | -18.7% |
| Q2 FY2022 | Jun 30, 2022 | $5.67M | -17.7% |
| Q1 FY2022 | Mar 31, 2022 | $5.84M | -39.7% |
| Q4 FY2021 | Dec 31, 2021 | $5.77M | -41.1% |
| Q3 FY2021 | Sep 30, 2021 | $5.51M | -53.5% |
| Q2 FY2021 | Jun 30, 2021 | $6.90M | -41.2% |
| Q1 FY2021 | Mar 31, 2021 | $9.69M | -15.5% |
| Q4 FY2020 | Dec 31, 2020 | $9.79M | +75.8% |
| Q3 FY2020 | Sep 30, 2020 | $11.85M | +102.5% |
| Q2 FY2020 | Jun 30, 2020 | $11.73M | +100.4% |
| Q1 FY2020 | Mar 31, 2020 | $11.47M | +247.7% |
| Q4 FY2019 | Dec 31, 2019 | $5.57M | +150.1% |
| Q3 FY2019 | Sep 30, 2019 | $5.85M | +722.1% |
| Q2 FY2019 | Jun 30, 2019 | $5.85M | +759.8% |
| Q1 FY2019 | Mar 31, 2019 | $3.30M | +434.3% |
| Q4 FY2018 | Dec 31, 2018 | $2.23M | +319.0% |
| Q2 FY2018 | Jun 30, 2018 | $712.17K | +68.0% |
| Q1 FY2018 | Mar 31, 2018 | $680.91K | +33.0% |
| Q4 FY2017 | Dec 31, 2017 | $617.48K | +83.2% |
| Q3 FY2017 | Sep 30, 2017 | $531.60K | -62.6% |
| Q2 FY2017 | Jun 30, 2017 | $423.89K | – |
| Q1 FY2017 | Mar 31, 2017 | $511.96K | – |
| Q4 FY2016 | Dec 31, 2016 | $337.12K | – |
| Q3 FY2016 | Sep 30, 2016 | $1.42M | – |
See a number that looks wrong?